|
MSH2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.554400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.599800E-01 |
| Normal-vs-Stage2 |
7.826800E-01 |
| Normal-vs-Stage3 |
5.486500E-02 |
| Normal-vs-Stage4 |
1.272150E-01 |
| Stage1-vs-Stage2 |
6.232400E-01 |
| Stage1-vs-Stage3 |
7.456000E-03 |
| Stage1-vs-Stage4 |
4.223900E-02 |
| Stage2-vs-Stage3 |
2.306600E-01 |
| Stage2-vs-Stage4 |
3.187400E-01 |
| Stage3-vs-Stage4 |
7.924800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.313200E-01 |
| Normal-vs-AfricanAmerican |
1.934580E-01 |
| Normal-vs-Asian |
9.053800E-01 |
| Caucasian-vs-AfricanAmerican |
2.941000E-01 |
| Caucasian-vs-Asian |
7.380600E-01 |
| AfricanAmerican-vs-Asian |
4.850800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.210000E-01 |
| Normal-vs-Female |
9.088200E-01 |
| Male-vs-Female |
6.132000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.197000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.833000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.242000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.569800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.622000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.185800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.752400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.950200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.002840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.680500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.118620E-01 |
| Normal-vs-Grade 2 |
4.287000E-01 |
| Normal-vs-Grade 3 |
5.672100E-02 |
| Normal-vs-Grade 4 |
1.612160E-02 |
| Grade 1-vs-Grade 2 |
3.056600E-01 |
| Grade 1-vs-Grade 3 |
4.479700E-03 |
| Grade 1-vs-Grade 4 |
3.382400E-03 |
| Grade 2-vs-Grade 3 |
5.408100E-04 |
| Grade 2-vs-Grade 4 |
9.837300E-04 |
| Grade 3-vs-Grade 4 |
1.860600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.813220E-01 |
| Normal-vs-ccB subtype |
1.100850E-01 |
| ccA subtype-vs-ccB subtype |
1.384270E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.013200E-01 |
| Normal-vs-N1 |
5.135000E-01 |
| N0-vs-N1 |
7.601000E-01 |
|
|
